Pharmaceuticals (Basel, Switzerland)
Microbiota-Driven Strategies for Managing IBD-Associated Risks: From Infections to Mental Health.
Patrycja Krynicka, Pablo Cortegoso Valdivia, Maciej Morawski, Wojciech Marlicz, Karolina Skonieczna-Żydecka, Anastasios Koulaouzidis
Published: 202610.3390/ph19010118
Abstract
Inflammatory bowel diseases (IBD) are increasingly acknowledged not merely as confined gastrointestinal disorders but as systemic immunometabolic syndromes. Central to this paradigm is the gut microbiota including non-bacterial components such as the…
Preview only. Read the full abstract at the source